Kevin Herde
2017 - Sorrento Therapeutics
In 2017, Kevin Herde earned a total compensation of $308.9K as Former EVP and Chief Financial Officer at Sorrento Therapeutics, a 61% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $143,899 |
| Other | $65,000 |
| Total | $308,899 |
Herde received $143.9K in salary, accounting for 47% of the total pay in 2017.
Herde also received $100K in bonus and $65K in other compensation.
Rankings
In 2017, Kevin Herde's compensation ranked 13,277th out of 14,666 executives tracked by ExecPay. In other words, Herde earned more than 9.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 13,277 out of 14,666 | 10th |
Division Manufacturing | 5,226 out of 5,772 | 10th |
Major group Chemicals And Allied Products | 1,892 out of 2,075 | 9th |
Industry group Drugs | 1,577 out of 1,731 | 9th |
Industry Biological Products, Except Diagnostic Substances | 289 out of 313 | 8th |
Source: SEC filing on July 19, 2018.
Herde's colleagues
We found four more compensation records of executives who worked with Kevin Herde at Sorrento Therapeutics in 2017.